Article citationsMore >>

Groves FD, Travis LB, Devesa SS, et al.: Waldenstrom’s macroglobulinemia: incidence patterns in the United States, 1988-1994. Cancer. 1998 Mar 15; 82(6): 1078-81.

has been cited by the following article:

Article

From Waldenstrom’s Macroglobulinemia to Creutzfeldt-Jakob Disease

1Internal Medicine Clerkship, Florida State University College of Medicine, Daytona Beach, FL, USA


American Journal of Medical Case Reports. 2020, Vol. 8 No. 1, 18-21
DOI: 10.12691/ajmcr-8-1-5
Copyright © 2019 Science and Education Publishing

Cite this paper:
Peter Rafferty. From Waldenstrom’s Macroglobulinemia to Creutzfeldt-Jakob Disease. American Journal of Medical Case Reports. 2020; 8(1):18-21. doi: 10.12691/ajmcr-8-1-5.

Correspondence to: Peter  Rafferty, Internal Medicine Clerkship, Florida State University College of Medicine, Daytona Beach, FL, USA. Email: Pr10e@med.fsu.edu

Abstract

Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare and fatal spongiform encephalopathy characterized by rapidly progressive dementia and myoclonus. The rarity of this disease and its variable initial presentation make early diagnosis fairly challenging, especially considering it is a diagnosis of exclusion. We present a case of a patient initially admitted for sudden onset of confusion, memory loss, dysmetria, and ataxia after a recent diagnosis of Waldenstrom’s Macroglobulinemia. Within four weeks, after work-up for suspected Bing-Neel syndrome and failure to respond to appropriate symptomatic treatment, acute deterioration of mental status, akinetic mutism, and myoclonus were evident & Cerebrospinal fluid (CSF) analysis was positive for protein 14-3-3. Brain magnetic resonance imaging (MRI) showed hyperintensities in the cortex and basal ganglia in diffusion-weighted imaging (DWI). The probable diagnosis of sCJD was reached based on the patient’s unresponsiveness to treatment, clinical features, characteristic findings on MRI, as well as positive 14-3-3 CSF assay.

Keywords